70 related articles for article (PubMed ID: 32423324)
1. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
Yekedüz E; Dursun B; Aydın GÇ; Yazgan SC; Öztürk HH; Azap A; Utkan G; Ürün Y
J Oncol Pharm Pract; 2020 Jul; 26(5):1289-1294. PubMed ID: 32423324
[TBL] [Abstract][Full Text] [Related]
2. Fatal SARS-CoV-2 infection in a renal transplant recipient.
Dirim AB; Demir E; Ucar AR; Garayeva N; Safak S; Oto OA; Yazici H; Alibeyoglu AM; Orhun G; Cagatay AA; Turkmen A
CEN Case Rep; 2020 Nov; 9(4):409-412. PubMed ID: 32564306
[TBL] [Abstract][Full Text] [Related]
3. Three Cases of COVID-19 Disease With Colonic Manifestations.
Sattar Y; Connerney M; Rauf H; Saini M; Ullah W; Mamtani S; Syed U; Luddington S; Walfish A
Am J Gastroenterol; 2020 Jun; 115(6):948-950. PubMed ID: 32427677
[No Abstract] [Full Text] [Related]
4. Viral exanthema as manifestation of SARS-CoV-2 infection: A case report.
Iancu GM; Solomon A; Birlutiu V
Medicine (Baltimore); 2020 Aug; 99(35):e21810. PubMed ID: 32871902
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy.
da Costa CM; de Souza ZS; Real Salgues AC; Harada G; Marino Rodrigues Ayres PP; Vieira Nunes DB; Katz A; Munhoz RR
Immunotherapy; 2020 Oct; 12(15):1133-1138. PubMed ID: 32900245
[No Abstract] [Full Text] [Related]
6. Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme.
Bapst T; Romano F; Müller M; Rohr M
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32601146
[No Abstract] [Full Text] [Related]
7. Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Firouzabadi FD; Firouzabadi MD; Ghalehbaghi B; Jahandideh H; Roomiani M; Goudarzi S
Med Hypotheses; 2020 Oct; 143():110067. PubMed ID: 32634735
[No Abstract] [Full Text] [Related]
8. Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy.
Serzan MT; Kumar PN; Atkins MB
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32434789
[TBL] [Abstract][Full Text] [Related]
9. Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
Ruíz-Quiñonez JA; Guzmán-Priego CG; Nolasco-Rosales GA; Tovilla-Zarate CA; Flores-Barrientos OI; Narváez-Osorio V; Baeza-Flores GDC; Gonzalez-Castro TB; López-Brito CR; Denis-García CA; Pérez-García A; Juárez-Rojop IE
PLoS One; 2021; 16(2):e0245394. PubMed ID: 33606711
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and immune checkpoint inhibitors: initial considerations.
Sullivan RJ; Johnson DB; Rini BI; Neilan TG; Lovly CM; Moslehi JJ; Reynolds KL
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32434790
[TBL] [Abstract][Full Text] [Related]
11. A Rare Case of Coronavirus Disease 2019 Survival in an Elderly Patient With Atheroembolic Renal Disease.
Cavanna L; Zaffignani E; Citterio C; De Amicis S; Scarpioni R
Cureus; 2021 Mar; 13(3):e14201. PubMed ID: 33948397
[TBL] [Abstract][Full Text] [Related]
12. Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic.
Souza IL; Fernandes Í; Taranto P; Buzaid AC; Schvartsman G
Eur J Cancer; 2020 Aug; 135():147-149. PubMed ID: 32585589
[No Abstract] [Full Text] [Related]
13. Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors.
Szabados B; Abu-Ghanem Y; Grant M; Choy J; Bex A; Powles T
Eur Urol; 2020 Aug; 78(2):276-280. PubMed ID: 32534910
[TBL] [Abstract][Full Text] [Related]
14. Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era.
Maio M; Hamid O; Larkin J; Covre A; Altomonte M; Calabrò L; Vardhana SA; Robert C; Ibrahim R; Anichini A; Wolchok JD; Giacomo AMD
Clin Cancer Res; 2020 Aug; 26(16):4201-4205. PubMed ID: 32540850
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19.
Yekedüz E; Utkan G; Ürün Y
Eur J Cancer; 2020 Dec; 141():92-104. PubMed ID: 33130550
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab.
Artigas C; Lemort M; Mestrez F; Gil T; Flamen P
Clin Nucl Med; 2020 Aug; 45(8):e381-e382. PubMed ID: 32520508
[TBL] [Abstract][Full Text] [Related]
17. Determinants of COVID-19 disease severity in patients with cancer.
Robilotti EV; Babady NE; Mead PA; Rolling T; Perez-Johnston R; Bernardes M; Bogler Y; Caldararo M; Figueroa CJ; Glickman MS; Joanow A; Kaltsas A; Lee YJ; Lucca A; Mariano A; Morjaria S; Nawar T; Papanicolaou GA; Predmore J; Redelman-Sidi G; Schmidt E; Seo SK; Sepkowitz K; Shah MK; Wolchok JD; Hohl TM; Taur Y; Kamboj M
Nat Med; 2020 Aug; 26(8):1218-1223. PubMed ID: 32581323
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in a melanoma patient under treatment with checkpoint inhibition.
Schmidle P; Biedermann T; Posch C
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e465-e466. PubMed ID: 32455475
[No Abstract] [Full Text] [Related]
19. Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.
Bersanelli M; Zielli T; Perrone F; Casartelli C; Pratticò F; Rapacchi E; Camisa R; Tognetto M; Clemente A; Giannarelli D; Rebuzzi SE; Leonetti A; Bordi P; Tiseo M; Buti S
Immunotherapy; 2020 Oct; 12(15):1139-1148. PubMed ID: 32933369
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
